---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290096308.md"
description: "Opus Genetics shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $8 price target."
datetime: "2026-06-17T17:04:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290096308.md)
  - [en](https://longbridge.com/en/news/290096308.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290096308.md)
---

# 

Opus Genetics shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $8 price target.

### Related Stocks

- [IRD.US](https://longbridge.com/en/quote/IRD.US.md)

## Related News & Research

- [Opus Genetics: FDA-Backed Phase 3 Path and Strong Early Efficacy Support Reiterated Buy on IRD with Unchanged $10 Price Target](https://longbridge.com/en/news/291831058.md)
- [Cantor Fitzgerald Reaffirms Their Buy Rating on Opus Genetics (IRD)](https://longbridge.com/en/news/292316425.md)
- [Opus Genetics: Buy Rating Reiterated as Analyst Sees Pivotal OPGx-BEST1 Data as Key Catalyst; $10 Price Target Unchanged](https://longbridge.com/en/news/292217299.md)
- [Opus Genetics to release 3-month Cohort 1 topline data for OPGx-BEST1 trial in September 2026](https://longbridge.com/en/news/292188211.md)
- [Li Bang International Announces 1-for-200 Share Consolidation | LBGJ Stock News](https://longbridge.com/en/news/294268950.md)